What safety measure should be put in place to avoid serious infection associated with a drug?

What safety measure should be put in place to avoid serious infection associated with a drug?

• A. Patient education of initial warning signs of infection prior to prescribing
• B. Routine lab monitoring after starting therapy
• C. Mandatory hospitalization for all patients
• D. Annual compliance reminder

Answer: (A)

Educating patients to recognize early warning signs of infection before and during therapy is the most effective way to prevent serious infections with drugs that increase infection risk. When patients know what to look for—fever, chills, persistent sore throat, cough, dysuria, wound changes, or any new or worsening symptoms—they can seek prompt medical evaluation. This allows the clinician to assess for infection quickly, pause or adjust the drug if needed, and start treatment early, reducing the chance that a mild infection progresses to a serious or life-threatening one. Routine lab monitoring after starting therapy can help detect problems, but it may not catch evolving infections early enough and does not directly prevent them. Mandatory hospitalization for all patients is impractical, and an annual compliance reminder doesn’t address the immediate risk.

Educating patients to recognize early warning signs of infection before and during therapy is the most effective way to prevent serious infections with drugs that increase infection risk. When patients know what to look for—fever, chills, persistent sore throat, cough, dysuria, wound changes, or any new or worsening symptoms—they can seek prompt medical evaluation. This allows the clinician to assess for infection quickly, pause or adjust the drug if needed, and start treatment early, reducing the chance that a mild infection progresses to a serious or life-threatening one.

Routine lab monitoring after starting therapy can help detect problems, but it may not catch evolving infections early enough and does not directly prevent them. Mandatory hospitalization for all patients is impractical, and an annual compliance reminder doesn’t address the immediate risk.